Alpha Tau Medical Email Format

Biotechnology ResearchJerusalem, Israel51-200 Employees

Alpha Tau Medical is a mid-sized biotechnology company based in Jerusalem, Israel, focused on the research, development, and commercialization of Alpha DaRT, a radiotherapy approach for solid tumors. The therapy traces its origins to work at Tel Aviv University and uses Radium-224 seeds implanted into tumors to release alpha-emitting decay products that destroy cancer cells while largely sparing surrounding healthy tissue. It is designed for delivery in clinical settings, offering potent, tumor-focused radiation in a single session and potentially combining with other therapies. The company is progressing its first clinical trials across multiple sites in the European Union and is expanding its network to more than 55 leading cancer centers worldwide.

In 2026, Alpha Tau announced a strategic collaboration with Tolmar International Ltd. to develop and commercialize Alpha DaRT for treating prostate cancer in the United States. The company also disclosed ongoing clinical activity, including presentations of pancreatic cancer data at major conferences that year.

Sign up for free to view info

Company overview Employee directory